| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.43 | 0.03 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |